The trademark application EMPRANDO was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on August 24, 2021, and it was registered by office on December 1, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on May 4, 2022. Change of name and address of the trademark registration was recorded on May 16, 2022.